Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
For the nine months, net loss was SEK 14.96 million compared to SEK 12.19 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0462 SEK | -7.60% | +10.00% | +0.43% |
1st Jan change | Capi. | |
---|---|---|
+0.43% | 828K | |
+44.48% | 55.07B | |
-0.86% | 41.79B | |
+44.13% | 40.22B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |